abiraterone in metastatic castration-sensitive prostate cancer
Published 3 years ago • 2K plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
2:59
niraparib and abiraterone acetate for metastatic castration-resistant prostate cancer
-
1:53
abiraterone vs docetaxel for metastatic castrate resistant prostate cancer
-
3:06
treatment intensification in metastatic castration-sensitive prostate cancer
-
2:13
head-to-head: tolerability of enzalutamide vs. abiraterone acetate for metastatic crpc
-
1:34
dr. chi on abiraterone versus enzalutamide for metastatic castration-resistant prostate cancer
-
1:30
bmi and clinical outcomes in patients with metastatic castration-resistant prostate cancer
-
2:10
current standards for first-line metastatic hormone-sensitive prostate cancer
-
0:45
treatment sequencing for metastatic castration-resistant prostate cancer
-
1:33
fih study of arv-110 in metastatic castrate-resistant prostate cancer
-
2:12
abiraterone for metastatic, hormone sensitive, prostate cancer
-
4:46
quality of life and new therapeutic options for metastatic castration-resistant prostate cancer
-
5:46
metastatic castration-resistant prostate cancer – new learnings and perspectives
-
1:22
advances in non-metastatic castration-resistant prostate cancer
-
1:17
abiraterone for the treatment of cn1 prostate cancer
-
1:16
drug development for metastatic castration-resistant prostate cancer
-
1:33
the role of radium 223 in metastatic castration resistant prostate cancer
-
1:41
the role of triplet therapy in men with metastatic castration sensitive prostate cancer
-
3:14
treatment with abiraterone acetate without steroids in mcrpc
-
2:41
recent developments in treatment options for castration-sensitive metastatic prostate cancer